Biotech and Pharmaceuticals Medicine

  • It is the first FDA- approved medicine for spinal muscular atrophy, a devastating disease that affects about one in 10,000 live births. The FDA approved it for use across the full range and severity of the disease. Annual Spinraza sales could reach $2 billion, according to RBC Capital Markets analyst Michael Yee.

  • Dec 23- Nearly two decades ago, several drugs to treat rheumatoid arthritis hit the shelves in rapid succession, opening up a huge market for the treatment of the autoimmune joint disorder. Most of those biologics- drugs made using living cells- went on to notch blockbuster sales. "Migraine today can be characterized as similar to RA in the past, in that it's a large...

  • BEIJING, Dec 23- Two people in China's Anhui province have died from H7N9 bird flu, the first fatalities in China among this winter's cases, while Macau reported its first human infection of the strain since the former Portuguese colony returned to China in 1999.. Anhui has reported five cases of H7N9 avian flu since Dec. 8, including the two people who died, the...

  • BEIJING, Dec 23- Two people in the Chinese province of Anhui have died of bird flu infection, the first fatalities among this winter's avian flu cases in China, as neighbours South Korea and Japan tried to curb their own outbreaks of the virus. Anhui has reported five cases of H7N9 avian flu since Dec. 8, including two deaths, the eastern province's health authority...

  • BEIJING, Dec 23- Two people in the Chinese province of Anhui have died of bird flu infection, the first fatalities among this winter's avian flu cases in China, as neighbours South Korea and Japan tried to curb their own outbreaks of the virus. Anhui has reported five cases of H7N9 avian flu since Dec. 8, including two deaths, the province's health authority said in a...

  • Under New Mexico regulations, healthcare facilities must report a suspected outbreak of C. difficile to the state Health Department within 24 hours. But Casa Maria staff did not contact authorities until March 4, 2014, according to the Health Department report on its investigation of the outbreak, a copy of which was obtained by Reuters. When a Health...

  • *Shanghai says treating man who traveled from Jiangsu. Health officials in nearby South Korea and Japan have been scrambling to contain outbreaks of different strains of bird flu, with the poultry industry there bracing for heavy financial losses. A man diagnosed with the H7N9 strain of bird flu is being treated in Shanghai, after traveling from the...

  • *Shanghai says treating man who travelled from Jiangsu. The discoveries come as health officials in nearby South Korea and Japan have been scrambling to contain outbreaks of different strains of the virus, with the poultry industry there bracing for heavy financial losses. A man diagnosed with the H7N9 strain of bird flu is being treated in Shanghai, after...

  • *Comes as S.Korea, Japan culling millions of birds. BEIJING, Dec 22- Chinese authorities have confirmed a second case of human bird flu infection this week, state media reported late on Wednesday, as South Korea and Japan battle to control outbreaks of the deadly virus. Both cases come as South Korea and Japan have ordered the killing of tens of millions of birds in...

  • VERDICT IS THIRD TIME DUPONT HAS BEEN FOUND LIABLE FOR DISEASES LINKED TO TEFLON CHEMICAL EXPOSURE.

  • The company's shares rose 6.6 percent to $7.39 in premarket trading on Wednesday. The Zika virus has spread to more than 60 countries and territories since the current outbreak was identified last year in Brazil, raising alarm over its ability to cause the rare birth defect microcephaly as well as other neurological disorders in infants and adults.

  • For pediatric brain tumors, ‘the science is here’

    Brain tumors are the leading cause of cancer-related deaths in children, yet researchers believe that they are close to developing promising new therapies that will fuel a cure.

  • Dec 21- Merrimack Pharmaceuticals Inc said it would stop a study testing its drug in advanced breast cancer patients, after an analysis suggested the drug would unlikely show superiority over chemotherapy. Merrimack's shares slumped 21.79 percent to $4.20 in premarket trading on Wednesday. Both sets of patients- on Merrimack's drug and on chemotherapy-...

  • Dec 21- Merrimack Pharmaceuticals Inc said on Wednesday it would stop a mid-stage study involving advanced breast cancer patients, following the recommendation of an independent panel.

  • *S.Korea cull at record 20 mln birds as China jitters grow. TOKYO/ MANILA, Dec 21- A virulent strain of airborne bird flu extended its shadow across northeast Asia as Japan launched a new chicken cull on a southern island, days after gassing hundreds of thousands of birds some 2,400 kilometers to the north. With South Korea just across the Yellow Sea from China,...

  • Dec 20- Akebia Therapeutics Inc said it signed a co-development and marketing deal worth up to $1 billion for its experimental anemia drug with Japan's Otsuka Holdings Co Ltd.. The companies will share the cost of selling the drug if and when it gets approved in the United States, Akebia said. The deal comes a year after Akebia signed an agreement with another...

  • *No approved drug by FDA for Alzheimer's psychosis. *Shares up 8.3 pct at $27.56. According to the Alzheimer's Association, an estimated 5.4 million people in the United States have the disease.

  • Acadia said a total of 181 patients were enrolled in the study in the UK and randomized on a one-to-one basis to receive either 34 mg of pimavanserin or placebo once everyday. The drug has been approved by the US Food and Drug Administration to treat hallucinations and delusions associated with Parkinson's disease psychosis, the company said.

  • Dec 20- Acadia Pharmaceuticals Inc said on Tuesday its drug to treat psychosis in patients suffering from Alzheimer's disease met its main goal in a mid-stage study. The drug has been approved by the US Food and Drug Administration to treat hallucinations and delusions associated with Parkinson's disease psychosis, the company said. Acadia said the FDA is yet...

  • LONDON, Dec 20- GlaxoSmithKline's already fast-growing HIV drug business has received an important boost after two major clinical studies successfully tested a new two-drug treatment regimen to control the virus that causes AIDS. GSK has developed the new two-drug cocktail through its majority-owned ViiV Healthcare, in which Pfizer and Shionogi also...